Skip Navigation



American Journal of Epidemiology Advance Access published online on December 13, 2008
American Journal of Epidemiology, doi:10.1093/aje/kwn360
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
169/4/473    most recent
kwn360v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Rosenberg, L.
Right arrow Articles by Palmer, J. R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Rosenberg, L.
Right arrow Articles by Palmer, J. R.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

American Journal of Epidemiology © The Author 2008. Published by the Johns Hopkins Bloomberg School of Public Health. All rights reserved. For permissions, please e-mail: journals.permissions@oxfordjournals.org.

Original Contribution

A Case-Control Study of Oral Contraceptive Use and Incident Breast Cancer

Lynn Rosenberg, Yuqing Zhang, Patricia F. Coogan, Brian L. Strom and Julie R. Palmer

Correspondence to Dr. Lynn Rosenberg, Slone Epidemiology Center at Boston University, 1010 Commonwealth Avenue, Boston, MA 02215 (e-mail: lrosenberg{at}slone.bu.edu).

Received for publication July 1, 2008. Accepted for publication October 10, 2008.

Oral contraceptive (OC) use has been linked to increased risk of breast cancer, largely on the basis of studies conducted before 1990. In the Case-Control Surveillance Study, a US hospital-based case-control study of medication use and cancer, the authors assessed the relation of OC use to breast cancer risk among 907 case women with incident invasive breast cancer (731 white, 176 black) and 1,711 controls (1,152 white, 559 black) interviewed from 1993 to 2007. They evaluated whether the association differed by ethnicity or tumor hormone receptor status. After control for breast cancer risk factors, the multivariable odds ratio for 1 year or more of OC use, relative to less than 1 year of use, was 1.5 (95% confidence interval: 1.2, 1.8). The estimates were similar within age strata (<50 years and ≥50 years). The odds ratios were larger for use within the previous 10 years, long-duration use, and black ethnicity, but these differences were not statistically significant. The association of OC use with breast cancer risk did not differ according to the estrogen or progestogen receptor status of the tumor. These results suggest that OC use is associated with an increased risk of breast cancer diagnosed in recent years.

breast neoplasms; case-control studies; contraceptives, oral

Abbreviations: CARE, Contraceptive and Reproductive Experiences; CI, confidence interval; ER, estrogen receptor; OC(s), oral contraceptive(s); PR, progestogen receptor


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
 Am J EpidemiolHome page
S. Shapiro
RE: "A CASE-CONTROL STUDY OF ORAL CONTRACEPTIVE USE AND INCIDENT BREAST CANCER"
Am. J. Epidemiol., September 15, 2009; 170(6): 802 - 803.
[Full Text] [PDF]

Home page
 Am J EpidemiolHome page
L. Rosenberg, Y. Zhang, P. F. Coogan, B. L. Strom, and J. R. Palmer
THE AUTHORS REPLY
Am. J. Epidemiol., September 15, 2009; 170(6): 803 - 804.
[Full Text] [PDF]


Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.